Francesca K. H. Gavins

University College London

Papers

2

Total Citations

169

H-Index

2

About

Dr. Francesca K. H. Gavins is a pioneering researcher at the intersection of pharmaceutical science and advanced manufacturing, whose work is redefining how medicines are designed and delivered. Her primary research areas include 3D printed pharmaceuticals, artificial intelligence in drug formulation, and robotic systems for preclinical drug screening. Dr. Gavins is best known for her landmark 2021 paper, "Harnessing artificial intelligence for the next generation of 3D printed medicines," which has garnered 166 citations and lays the groundwork for AI-driven, personalized dosage forms. This work demonstrates how machine learning can optimize the printing of patient-specific tablets, a leap toward on-demand, precision medicine. She also contributed to "Robotic screening of intestinal drug absorption" (2020), showcasing her innovative use of automation to accelerate early-stage drug development. Her impact is measured not only in citations but in her role as a thought leader bridging computational modeling with tangible pharmaceutical manufacturing. Dr. Gavins’ research promises to transform pharmacy practice, making customised treatments faster, cheaper, and more accessible—a vision that positions her as a key figure in the future of digital therapeutics.

Research Focus

Key Achievements

2
H-Index
2
Papers
169
Total Citations
85
Avg Citations/Paper
🏆 Most Cited Paper
Harnessing artificial intelligence for the next generation of 3D printed medicines
166 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University College London

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago